Slide 1: Getinge Group Year end report January–December 2011
GETINGE GROUP Year end report January – December 2011 26 January 2012 Johan Malmquist, CEO Ulf Grunander, CFO
Slide 2: Q4 2011 – Summary
Q4 2011 – Summary Improving demand situation and order intake Good EBITA-margin development Strong Cash flow Completion of Atrium acquisition Further restructuring activities within the Cardiovascular division 2
Slide 3: Q4 2011 - Trends in organic order intake
Q4 2011 - Trends in organic order intake 2011 2011 Q4 YTD MS EC IC TOT MS EC IC TOT Europe 4.8% -1.2% -13.3% -1.5% 3.9% -4.3% -3.3% -0.7% USA and Canada -6.7% 2.7% -11.0% -5.2% 0.7% 6.6% -2.2% 1.7% Rest of the world 31.3% 6.9% 9.4% 23.0% 10.7% 9.8% 23.9% 13.3% Total 10.7% 1.2% -6.9% 4.0% 5.4% 1.2% 3
Slide 4: Consolidated results
Q4 2011 - Consolidated results 2011 2010 Change 2011 2010 Change Strong revenue growth Q4 Q4 % YTD YTD % Further strengthening of Net sales, SEK million 7 354 6 641 10.7% 21 854 22 172 -1.4% EBITA-margin Additional measures to Gross margin 51.7% 51.6% 0.1% 52.2% 51.3% 0.9% Operating cost, SEK
Slide 5: Q4 2011 - Medical Systems' results
Q4 2011 - Medical Systems’ results 2011 2010 Change 2011 2010 Change % % Q4 Q4 YTD YTD Net sales, SEK million 3 847 3 379 13.9% 11 031 11 195 -1.5% Gross margin % 58.8% 58.6% 0.2% 57.7% 58.0% -0.3% Operating cost, SEK million -1 201 -1 129 6.4% -4 234 -4 372 -3.2% EBITA before restructuring 1 174 94
Slide 6: Q4 2011 - Medical Systems' highlights
Q4 2011 - Medical Systems’ highlights Acquisition of Atrium Medical completed Restructuring of the Perfusion production on track. Savings of 60 Mkr p. a. New restructuring efforts in the Cardiovascular division will lead to annual savings of 80 Mkr from 2013. 6
Slide 7: Q4 2011 - Extended Care's results
Q4 2011 - Extended Care’s results 2011 2010 Change 2011 2010 Change % % Q4 Q4 YTD YTD Net sales , SEK million 1 647 1 585 3.9% 5 751 6 033 -4.7% Gross margin % 48.8% 48.3% 0.5% 51.8% 49.3% 2.5% Operating cost, SEK million -475 -485 -2.1% -1 800 -1 904 -5.5% EBITA before restructuring 352 306 15.0% 1
Slide 8: Q4 2011 - Infection Control's Results
Q4 2011 - Infection Control’s Results 2011 2010 2011 2010 Change Change % Q4 Q4 % YTD YTD Net sales, SEK million 1 860 1 677 10.9% 5 072 4 944 2.6% Gross margin % 39.7% 40.5% -0.8% 40.5% 38.5% 2.0% Operating cost, SEK million -346 -350 -1.1% -1 268 -1 225 3.5% EBITA before restructuring 395 332 19.0
Slide 9: Q4 2011 - Infection Control's highlights
Q4 2011 - Infection Control’s highlights New customer centric organisation for improved focus and profitability Acquisition of French service company 9
Slide 10: Financials
Financials 2011 2010 2011 2010 Q4 Q4 YTD YTD Cash flow from operation, SEK million 1 424 1 084 3 496 4 124 Cash conversion, % 65.1% 80.7% Net Debt, SEK million 17 109 13 377 Equity, SEK million 14 636 13 248 Equity/assets ratio, % 35.3% 38.3% Net debt/equity ratio, multiple 1.17 1.01 10
Slide 11: Outlook 2012
Outlook 2012 We expect earnings growth to remain solid Organic revenue growth to exceed 2011 levels Efficiency gains from supply chain improvements Declining restructuring costs Earnings contribution from Atrium 11
Slide 12: Questions
GETINGE GROUP QUESTIONS
Slide 13: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge Group’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expec